Kinetic and Immunophenotypic Heterogeneity in Acute Myeloid Leukemia Subpopulations

References

• Raza A., Makeshuvari Y., Preisler H. Differences in cell cycle characteristic among patients with acute non lymphocytic leukemia. Blood 1987; 69: 1647–1653
   PubMed Web of Science ®Google Scholar
• Hart J. S., George S. L., Frei E., III, Bodey G. P., Nickerson R. C., Freireich E. J. Prognostic significance of pretreatment proliferative activity in adult leukemia. Cancer 1977; 39: 1603, 1609
   PubMed Web of Science ®Google Scholar
• Colly L. P., Peters W. G., Hermans J., Arentsen-Honolers W., Willemze R. Percentage of S-phase cells in bone marrow aspirates, biopsy specimens and bone marrow aspirates corrected for blood dilution from patients with acute leukemia. Leuk. Res 1987; 11: 209–214
   PubMed Web of Science ®Google Scholar
• Raza A., Yasin Z., Grande S. A comparison of the rate of DNA synthesis in myeloblasts from peripheral blood and bone marrows of patients with acute non lymphocytic leukemia. Exp. Cell, Res 1988; 176: 13–19
   PubMed Web of Science ®Google Scholar
• Riccardi A., Danova M., Montecucco C., Ucci G., Cassano E., Giordano M., Mazzini G., Giordano P. Adult acute non lymphoblastic leukemia: reliability and prognostic significance of pretreatment bone marrow S-phase size determined by flow cytometry 1986. Scand. J. Haemat 1986; 36: 11–17
   PubMedGoogle Scholar
• Bennet J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A. G., Gralnick H. R., Sultan C. Proposals for the classification of acute leukemias. Br. J. Haemat 1976; 33: 451–458
   PubMed Web of Science ®Google Scholar
• Bennet J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A. G., Gralnick H. R., Sultan C. Criteria for the diagnosis of acute leukemia of megakaryocyte lineage. Ann. Intern. Med 1985; 103: 460–465
   PubMed Web of Science ®Google Scholar
• Bennet J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A. G., Gralnick H. R., Sultan C. Proposed revised criteria for the classification of acute myeloid leukemia. Ann. Intern. Med 1985; 103: 626–632
   PubMedGoogle Scholar
• Boyum A. Separation of leukocytes from blood and bone marrow. Scand. J. Clin. Lab. Invest 1968; 21, Suppl. 97
   Google Scholar
• Cordell J. L., Falini B., Erber W. N., Ghosh A. K., Abdulaziz Z., McDonald S., Pulford K. A. F., Stein H., Mason D. Y. Immunoenzymatic labelling of monoclonal antibodies using immunocomplexes of alkaline phosphatase and monoclonal anti alkaline phosphatase (APAAP complexes). J. Histochem. Cytochem 1984; 32: 219–225
   PubMed Web of Science ®Google Scholar
• Campos L., Guyotat D., Getilhomme O., Treille D., Archimbaud E., Fiere D., Germain D. Surface markers in acute non lymphoid leukemia: Analysis with a panel of 36 monoclonal antibodies. Blut 1987; 54: 65–71
   PubMedGoogle Scholar
• Drexler H. G. Classification of acute myeloid leukemias. A comparison of FAB and immunophenotyping. Leukemia 1987; 1: 697–702
   PubMed Web of Science ®Google Scholar
• Griffin J. D., Davis R., Nelson D. A., Davey F. R., Mayer R. J., Schiffer C., McIntyre R., Bloomfield C. D. Use of surface marker analysis to predict outcome of adult acute myeloblastic leukemia. Blood 1986; 68: 1232–1237
   PubMed Web of Science ®Google Scholar
• Neame P. B., Soamboonsrup P., Browman G., Meyer R. M., Benger A., Edwin C., Wilson C., Walker I. R., Saeed N., McBride J. A. Classifying acute leukemia by immunophenotyping: A combined FAB immunologic classification of AML. Blood 1986; 68: 1355–1363
   PubMed Web of Science ®Google Scholar
• San Miguel J. F., Gonzalez M., Canizo M. C., Anta J. P., Zola H., Lopez Borrasca A. Surface marker analysis in acute myeloid leukemia and correlation with FAB classification. Br. J. Haemat 1986; 64: 547–551
   PubMed Web of Science ®Google Scholar
• Schwonzen M., Kuehn N., Vetten B., Dihel V., Pfreundschuh M. Phenotyping of acute myelomonocytic (AMMOL) and monocytic leukemia (AMOL): Association of T cell related antigens and skin infiltration. Leuk. Res 1989; 13: 893–898
   PubMed Web of Science ®Google Scholar
• Scott C. S., Stark A. N., Limbert H. J., Master P. S., Head C., Roberts B. E. Diagnostic and prognostic factors in acute monocytic leukemia and correlation with FAB classification. Br. J. Haemat 1988; 64: 547–552
   Web of Science ®Google Scholar
• Davey F. R., Erber W. N., Gatter K. C., Mason D. Y. Immunophenotyping of acute myeloid leukemia by immunoalkaline phosphatase (APAAP) labelling with a panel of antibodies. An. J. Haemat 1987; 26: 157–166
   PubMed Web of Science ®Google Scholar
• Scott C. S., Morgan M. A. M., Limbert H. J., McKarill I. D., Roberts B. E. Cytochemical, immunological and ANAE isoenzyme studies in acute myelomonocytic leukaemia: A study of 39 cases. Scand. J. Haemat 1985; 35: 284–291
   PubMedGoogle Scholar
• Scott C. S., Richards S. J., Master P. S., Kendall J., Limbert H. J., Roberts B. E. Flow cytometric analysis of membrane CD11b, CD11c and CD14 expression in acute myeloid leukemia: relationship with monocytic subtypes and the concept of relative antigen expression. Eur. J. Haematol 1990; 44: 24–29
   PubMed Web of Science ®Google Scholar
• Griffin J. D., Rits J., Nadler L. M., Schlessman S. F. Expression of myeloid differentiation antigens on normal and malignant myeloid cells. J. Clin. Invest 1981; 68: 31–41
   Google Scholar
• Ost A., Cristensson B., Andreasen R., Hast R., Lagerloff B., Reizenstein P., Trowbridge I. S., Biberfeld P. Immunophenotype heterogeneity in AML. Scand. J. Haematol 1985; 34: 293–302
   PubMedGoogle Scholar
• Pessano S., Palumbo A., Ferrero D., Pagliardi G. L., Bottero L., Kai Lai S., Meo P., Carter C., Hubbell H., Lange B., Rovera G. Subpopulation heterogeneity in human acute myeloid leukemia determined by monoclonal antibodies. Blood 1984; 64: 275–281
   PubMed Web of Science ®Google Scholar
• Sabbath K. D., Ball E. D., Larcom P., Davis R. B., Griffin J. D. Heterogeneity of clonogenic cells in acute myeloblastic leukemia. J. Clin. Invest 1985; 75: 746–753
   PubMed Web of Science ®Google Scholar
• Sacchi S., Marietta M., Vecchi A., Morselli S., Longo R., Grande A., Torelli U. The use of the Alkaline Phosphatase anti Alkaline Phosphatase technique for immunophenotyping acute myeloid leukemia. Acta. Haematol 1991; 85: 6–11
   PubMed Web of Science ®Google Scholar
• Kabral A., Bradstock K. F., Grimsley P., Favaloro J. Immunophenotype of clonogenic cells in myeloid leukemia. Leuk. Res 1988; 12: 51–59
   PubMed Web of Science ®Google Scholar
• Griffin J. D., Larcom P., Schlossman S. Use of surface markers to identify a subset of acute myelomonocytic leukemia cells with progenitor cell properties. Blood 1983; 62: 1300–1303
   PubMed Web of Science ®Google Scholar
• Saito N. Acute myelomonocytic leukemia: an immunoelectron microscopic study. Am. J. Haematol 1990; 35: 238–246
   PubMed Web of Science ®Google Scholar
• Gadd S. Report on unclustered antibodies. Leucocyte typing IV white cell differentiation antigen, K. Knapp, B. Dorker, W. R. Gilks, E. P. Rieder, R. E. Schidt, H. Stein, A. E. G. K. R. von dem Borne. Oxford University Press, Oxford 1989; 846–850; 846–850, Schidt, R. E., Stein, H., von dem Borne, A. E. G. K. R. Leucocyte typing IV white cell differentiation antigen. Oxford University Press
   Google Scholar